FindTrial
Sign In

To compare and assess among participants receiving intrathecal 0.5% hyperbaric levobupivacaine and 0.5% hyperbaric bupivacaine for lower abdominal surgeries among 70 participants in each group.

Inthrathecal levobupivacaine vs bupivacaine for infraumbilical surgery:A randomized control trial - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078272
Enrollment
70
Registered
2024-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: O.5% Hyperbaric bupivacaine and 0.5% hyperbaric levobupivacaine intrathecally: 1.After lumbar puncture in spinal anesthesia with 0.5%hyperbaric bupivacaine 3ml given intrathecally.2.a

Sponsors

JSS Academy of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: age :18-60 yrs,either sex ,ASA 1 and 2,patients undergoing infraumbilical surgery under spinal anaesthesia

Exclusion criteria

Exclusion criteria: spinal anomalies,contraindications to spinal anaesthesia, ASA 3 and 4,deranged coagulation profile,local infection at the surgical site

Design outcomes

Primary

MeasureTime frame
to compare the sensory and motor block of 0.5% hyperbaric levo bupivacaine and o.5% hperbaric bupivacaineTimepoint: From time of spinal anaesthesia and noted at 0 minutes,5 minutes till 330 minutes—

Secondary

MeasureTime frame
To asses the sensory & motor block onset time ,total duration,asses & compare the side effects of hyperbaric bupivacaine & levobupivacaineTimepoint: From the time of spinal anesthesia & noted at 0 minutes,5 minutes till 330 minutes.Till the patient feel pain at incision site—

Countries

India

Contacts

Public ContactDr.Dinesh Kumar

JSS Hospital Mysuru

drdinu80@gmail.com9663237722

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026